User contributions
From silico.biotoul.fr
(Latest | Earliest) View (newer 20) (older 20) (20 | 50 | 100 | 250 | 500)
- 11:40, 4 September 2019 (hist) (diff) Enseignements (→Biologie Computationnelle)
- 15:30, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 6: analyse des résultats)
- 15:29, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 6: analyse des résultats)
- 15:29, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 6: analyse des résultats)
- 15:28, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 6: analyse des résultats)
- 15:23, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 6: analyse des résultats)
- 15:22, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 6: analyse des résultats)
- 15:20, 3 September 2019 (hist) (diff) M2R ADAM (→IPM60 chromato et IPM61 chromato.)
- 15:20, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 6: analyse des résultats)
- 15:20, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 6: analyse des résultats)
- 14:52, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 5: séquençage)
- 14:52, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 4: définition d'amorces)
- 14:51, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 4: définition d'amorces)
- 14:50, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 4: définition d'amorces)
- 14:47, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 3: identification in silico des clones recombinants positifs)
- 14:45, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 3: identification in silico des clones recombinants positifs)
- 14:44, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 2: création d'une carte du plasmide pVX-CBEL)
- 14:43, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 2: création d'une carte du plasmide pVX-CBEL)
- 14:36, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 2: création d'une carte du plasmide pVX-CBEL)
- 14:31, 3 September 2019 (hist) (diff) M2R ADAM (→Etape 1: choix des enzymes de restriction adaptées pour le clonage dans le vecteur pVX)
(Latest | Earliest) View (newer 20) (older 20) (20 | 50 | 100 | 250 | 500)